Predicting the effectiveness of choleretic therapy for functional disorders of the gallbladder and the sphincter of Oddi in children
Keywords:functional disorders of the gallbladder and sphincter of Oddi, choleric therapy, ursodeoxycholic acid, prediction, mathematical model, children
Background. Early detection of functional disorders of the gallbladder and the sphincter of Oddi in children and timely prescription of effective choleric therapy becomes important at the present stage. The purpose of the study was to determine prognostic risk factors for the development of functional disorders of the gallbladder and the sphincter of Oddi in children and to predict the effectiveness of choleric therapy with the addition of ursodeoxycholic acid (UDCA). Materials and methods. Seventy children with functional disorders of the gallbladder and the sphincter of Oddi aged 4 to 14 years were examined and treated. One hundred and forty clinical-laboratory, molecular-genetic and instrumental-diagnostic parameters were analyzed with the help of Wald’s sequential analysis. Relative risk (RR) and diagnostic coefficient were calculated for each of them. Results. Risk factors for the development of functional disorders of the gallbladder and the sphincter of Oddi were the presence of functional disorders of the gallbladder and the sphincter of Oddi in the father and relatives by maternal lineage (RR is 1.60 and 1.60, respectively), body weight at birth less than 3 kg (RR = 1.95), the onset of the first episode of clinical and paraclinic manifestations at the age of 2 to 6 years (RR = 1.47), the levels of biochemical hepatogram indicators: cholesterol — 43.7–52.0 mmol/l (RR = 1.83), aspartate aminotransferase — 45.0–59.0 n/l (RR = 3.21) and alanine aminotransferase — 28.3–38.0 n/l (RR = 3.21). High efficiency of choleric therapy with the addition of UDCA drugs in functional disorders of the gallbladder and the sphincter of Oddi in children was established (RR = 4.13). The use of UDCA as a part of choleric therapy in the past medical history is of significant importance (RR = 3.67). It was found that after receiving treatment, the levels of expression of microRNA-378f — 3.07–6.14 c.u. (RR = 0.37), microRNA-4311 — 2.51–5.01 c.u. (RR = 0.18), microRNA-4714-3p — 3.19–6.38 c.u. (RR = 0.31) are determined in children as a protective factor. Mathematical models have been developed that can be used to evaluate the risk of developing functional disorders of the gallbladder and the sphincter of Oddi in children and the effectiveness of choleric therapy. Conclusions. High efficiency and simplicity in the use of mathematical models for determining the risk of functional disorders of the gallbladder and the sphincter of Oddi in children and predicting the effectiveness of choleric therapy with the addition of ursodeoxycholic acid allow us to recommend them in the practice of a pediatrician, family physician and pediatric gastroenterologist for timely prescription of rational therapy and checking its effectiveness.
Abaturov AE, Zavgorodniaia NIu, Babich VL. MikroRNK pri zabolevaniiakh gepatobiliarnoi sistemy [MicroRNA for diseases of the hepatobiliary system]. Dnipro: Dominanta Print; 2018: 336 p. (in Russian).
Abaturov AE, Babich VL. The efficacy of applying ursodeoxycholic acid in functional disorders of the gall bladder and Oddi sphincter in children. World of medicine and biology. 2019;(67):7-11. doi: 10.26724/2079-8334-2019-1-67-7. (in Ukrainian).
Abaturov AE, Babich VL. Drug modulation of activity of microRNA generation in functional disorders of the gallbladder and sphincter of Oddi in children. Zdorovʹe rebenka. 2019;14(2):89-95. doi: 10.22141/2224-05184.108.40.2069.165544. (in Ukrainian).
Vakhrushev YaM, Khokhlacheva NA, Mikheeva PS, Suchkova EV. The mechanisms of the disorders of motor-evacuation function of gall bladder and their importance in the development of cholelithiasis. Arhivʺ vnutrennej mediciny. 2018;8(39):53-58. doi: 10.20514/2226-6704-2018-8-1-53-58. (in Russian).
Volosoveс OP, Zubarenko OV, Kryvopustov SP, et al. Pediatrija (gastroenterologija ta patologija rann'ogo viku): navchal'nyj posibnyk [Pediatrics (gastroenterology and pathology of the early age): study guide]. Odessa: Druk Pivden'; 2017. 165-180 pp. (in Ukrainian).
Dvoirin VV, Klimenkov AA. Metodika kontroliruemykh ispytanii [The methodology of controlled trials]. Moscow: Medicine; 1985. 144 p. (in Russian).
Ministry of Нealth of Ukraine. Order on January 29, 2013 № 59. On Adoption Of Unified Clinical Protocols for Medical Care for Children with Digestive Diseases. Available from: https://zakon.rada.gov.ua/rada/show/v0059282-13. Accessed: January 29, 2013. (in Ukrainian).
Castro RE, Ferreira DMS, Afonso MB, et al. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. J Hepatol. 2013 Jan;58(1):119-25. doi: 10.1016/j.jhep.2012.08.008.
Katsushima F, Takahashi A, Sakamoto N, Kanno Y, Abe K, Ohira H. Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients. Hepatol Res. 2014 Oct;44(10):E189-97. doi: 10.1111/hepr.12198.
Letelier P, Riquelme I, Hernández AH, Guzmán N, Farías JG, Roa JC. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers. Int J Mol Sci. 2016 May 23;17(5). pii: E791. doi: 10.3390/ijms17050791.
Tabibian JH, Lindor KD. Ursodeoxycholic Acid Treatment in Primary Sclerosing Cholangitis. In: Forman LM, editor. Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Developments. Geneva, Switzerland: Springer International Publishing; 2017. 145-152 pp. doi: 10.1007/978-3-319-40908-5_11.
Copyright (c) 2019 A.E. Abaturov, V.L. Babуch
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.